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ABSTRACT: A direct method for the regioselective construction of benzimidazolones is reported wherein a single palladium
catalyst is employed to couple monosubstituted urea substrates with diﬀerentially substituted 1,2-dihaloaromatic systems. In this
method, the catalyst is able to promote a cascade of two discrete chemoselective C−N bond-forming processes that allows the
highly selective and predictable formation of complex heterocycles from simple, readily available starting materials.
The catalytic formation of carbon−nitrogen bonds is acentral research focus in our laboratory,1 and we have a
longstanding interest in applying C−N cross-coupling methods
to the selective construction or functionalization of valuable
heterocycles.2 Benzimidazolones are present in a range of
biologically active small molecules that impact processes that
are relevant to cancer,3 inﬂammation,4 HIV,5 pain regulation,6
and others.7 There are methods that allow the direct
benzimidazolone functionalization, but the reactivities of the
two nitrogen atoms contained in the cyclic urea are very similar
and, as a result, regioselectivity in these processes has typically
been achieved through the use of protecting groups.8 However,
a number of regiospeciﬁc approaches have emerged that involve
diﬀerentiation of the nitrogen atoms prior to heterocycle
assembly. Two of the most commonly employed strategies
involve carbonylation of phenylenediamine derivatives3−7
(using phosgene or similar electrophiles, eq 1) or cyclization
of functionalized phenylureas9 (eq 2).
We recently described a regioselective approach to
benzimidazole synthesis that operates through a cascade of
C−N bond-forming reactions.10 In this system, a single
palladium catalyst mediates the selective coupling of bifunc-
tional aryl electrophiles with two diﬀerent nitrogen-based
nucleophiles to aﬀord the heterocyclic products. We questioned
whether a similar approach could be developed to deliver
complex benzimidazolones directly. More speciﬁcally, we
understood that chemoselective oxidative addition11 of a
phosphine-ligated palladium(0) catalyst into ortho-bromochlor-
obenzene substrate 1 would give rise to the arylpalladium(II)
bromide complex 4 (as shown in eq 3). Preferential arylation of
the primary urea12 (contained in nucleophile 2) would aﬀord
the 2-chloroaniline derivative 5, and an intramolecular coupling
sequence (via intermediate 6) would deliver the benzimidazo-
lone 3. If successful, the outlined process would grant access to
functionalized benzimidazolone structures in a single step from
commercially available or readily accessible starting materials,
potentially with high levels of regiocontrol.
To evaluate the feasibility of the proposed cascade process,
we treated 2-bromo-1-chloro-4-ﬂuorobenzene with 1.2 equiv of
benzylurea, 2.4 equiv of an inorganic base, and a series of
palladium precatalysts (a selection of which are shown in Table
1) at 110 °C for 14 h. Although t-BuBrettPhos13 and
XantPhos12 are capable supporting ligands for palladium-
mediated urea arylation, we found that the catalyst based on
BrettPhos was uniquely able to perform both coupling steps of
the detailed cascade. In the presence of 5 mol % BrettPhos
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palladium(II) mesylate precatalyst (P1),14 the substrates
reacted smoothly to provide the corresponding 5-ﬂuoro-
substituted benzimidazolone as a single regioisomer with good
eﬃciency (entry 3, 85% 19F NMR yield). While inorganic
carbonate bases were also capable of promoting this trans-
formation (entries 4 and 5), a decrease in product yield was
observed when dioxane or toluene were used as solvent (entries
6 and 7).
To assess the substrate scope of this cascade transformation,
2-bromo-1-chloro-4-ﬂuorobenzene was coupled with a range of
ureas under standard conditions. As shown in Table 2, a
number of alkyl-substituted ureas, including electronically
diverse benzylurea derivatives, gave rise to the corresponding
5-ﬂuoro-1-alkylbenzimidazolones in good yield (Table 2,
entries 1−5). Unfortunately, we found that the incorporation
of electron-rich arylurea systems was ineﬃcient under these
conditions (presumably due to instability of the intermediate 2-
chloroarylurea),15 but electron-neutral substrates could be
employed to give the desired heterocycles in synthetically
acceptable yields (entries 6 and 7). Notably, the outlined
conditions aﬀorded the desired heterocycles with complete
regioselectivity.
We then turned our attention to evaluating the scope of the
electrophile in this process. As shown in Scheme 1, these
catalytic conditions allowed us to unite a collection of
substituted 2-bromochlorobenzene derivatives with benzylurea
to give the corresponding complex heterocycles. In addition to
methyl groups (3a and 3d), electron-withdrawing substituents,
including triﬂuoromethyl (3c and 3f), cyano (3g), ester (3h),
and amide (3i) groups, were tolerated in this process (51−83%
yield) and again the products were obtained in regioisomeri-
cally pure form. Furthermore, we found that the selective
coupling of 2,3-dichloropyridine could be achieved under
standard conditions to aﬀord exclusively the 1-substituted
imidazo[4,5-b]pyridin-2-one in moderate yield.
In summary, we describe a novel approach to regioselective
benzimidazolone construction that operates through a cascade
of two discrete palladium-catalyzed C−N bond-forming
reactions. In this process, the heterocyclic products are formed
with complete regiocontrol that stems from the chemoselective
Table 1. Optimization of the Reaction Conditionsa
entry precatalyst solvent base NMR yield
1 P3 t-BuOH K3PO4 0%
2 P2 t-BuOH K3PO4 0%
3 P1 t-BuOH K3PO4 85%
4 P1 t-BuOH K2CO3 77%
5 P1 t-BuOH Cs2CO3 68%
6 P1 dioxane K3PO4 75%
7 P1 PhMe K3PO4 0%
aReactions were performed on a 0.2 mmol scale; yield was determined
by 19F NMR using 1-ﬂuoronaphthalene as an internal standard;
complete regioselectivity was observed in all cases.
Table 2. Regioselective Benzimidazolone Synthesis: Scope of
the Urea Coupling Partnera
entry R equiv urea yieldb
1 Me 2.5 76%
2 Bu 2.5 85%
3 2-F-Bn 1.5 75%
4 4-CF3-Bn 4.0 76%
5 4-MeO-Bn 1.5 78%
6 Ph 4.0 70%
7 4-F-C6H4 4.0 59%
aReaction conditions: ArBr (1.0 mmol), urea (1.5−4.0 mmol), K3PO4
(2.4 mmol), precatalyst P1 (0.05 mmol), t-BuOH (4.0 mL), 110 °C,
14 h. bIsolated yield (average of two runs).
Scheme 1. Cascade Approach to Benzimidazolones: Scope of
the Electrophilea
aReaction conditions: ArBr (1.0 mmol), benzylurea (1.5−4.0 mmol),
K3PO4 (2.4 mmol), precatalyst P1 (0.05 mmol), t-BuOH (4.0 mL),
110 °C, 14 h; isolated yields (average of two runs). b 1.2 equiv of
benzylurea. c 2.5 equiv of benzylurea. d 4.0 equiv of benzylurea. e
Reaction conducted with 3 mol % P1. f 2,3-Dichloropyridine used as
starting material. g 2,3-Dichloropyrazine used as starting material.
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nature of two diﬀerent fundamental catalytic operations,
namely oxidative addition of the palladium catalyst to Ar−Br
bonds in the presence of Ar−Cl bonds and preferential C−N
bond formation of primary urea nitrogen atoms. Finally, this
method utilizes a commercially available palladium precatalyst
and simple starting materials to provide direct and selective
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